Defining and predicting transdiagnostic categories of neurodegenerative disease
- 3 August 2020
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (8) , 787-800
Abstract
The prevalence of concomitant proteinopathies and heterogeneous clinical symptoms in neurodegenerative diseases hinders the identification of individuals who might be candidates for a particular intervention. Here, by applying an unsupervised clustering algorithm to post-mortem histopathological data from 895 patients with degeneration in the central nervous system, we show that six non-overlapping disease clusters can simultaneously account for tau neurofibrillary tangles, α-synuclein inclusions, neuritic plaques, inclusions of the transcriptional repressor TDP-43, angiopathy, neuron loss and gliosis. We also show that membership to the six transdiagnostic disease clusters, which explains more variance in cognitive phenotypes than can be explained by individual diagnoses, can be accurately predicted from scores of the Mini-Mental Status Exam, protein levels in cerebrospinal fluid, and genotype at the APOE and MAPT loci, via cross-validated multiple logistic regression. This combination of unsupervised and supervised data-driven tools provides a framework that could be used to identify latent disease subtypes in other areas of medicine.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (F30 MH118871-01)
- National Science Foundation (IIS-1926757)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1-R01-NS-099348-010)
This publication has 91 references indexed in Scilit:
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in NeuronsCell, 2013
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseasesActa Neuropathologica, 2012
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010Journal of Neuropathology & Experimental Neurology, 2012
- A Network Diffusion Model of Disease Progression in DementiaNeuron, 2012
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Basic statistical analysis in genetic case-control studiesNature Protocols, 2011
- Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapsesNeurobiology of Aging, 2010
- Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysisNeuroImage, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer DiseaseJournal of Biological Chemistry, 2009